Ownership history in BRAIDWELL LP · 3 quarters on record
This page tracks every 13F SEC filing in which BRAIDWELL LP reported a position in ACADIA PHARMACEUTICALS INC (ACAD). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 2,032,021 | -346,634 | -14.6% | 1.74% | $54.3M | $26.71 |
| 2025 Q3 | ADDED | 2,378,655 | +885,534 | +59.3% | 1.51% | $50.8M | $21.34 |
| 2022 Q4 | INITIATED | 1,493,121 | — | — | 0.80% | $23.8M | — |
As of 2025 Q4 — sorted by position size